Emirates Health Services Unveils Innovative Family Health Projects At Arab Health 2025
Emirates Health Services (EHS) is participating in the 50th Arab Health 2025 event under the theme "Future Health Now." This event, held at the Dubai World Trade Centre, runs from tomorrow until 30th January. As the exclusive health services partner, EHS is unveiling 19 innovative projects, with 13 being introduced for the first time both regionally and globally.
EHS has a dedicated section called "Family Health and Community Care," showcasing three innovative projects. Two of these are debuting on regional and global stages in collaboration with international partners. Dr. Essam Al Zarooni, Acting Executive Director of the Medical Services Sector at EHS, highlighted that families are central to Emirati society and their care is a national priority.

Dr. Al Zarooni stated, "Our participation in Arab Health 2025 reflects our wise leadership’s vision, which places the well-being of society at the forefront of its priorities. Families form the foundation of communities, and investing in their health reaffirms our commitment to enhancing quality of life, fostering psychological and social stability, and securing a dignified, sustainable lifestyle for all members of the Emirati family." These projects aim to provide advanced healthcare services to families for improved quality of life.
The "Usrati Bundle" is a notable project within this theme. Developed with the Federal Authority for Identity, Citizenship, Customs and Port Security, and the Telecommunications and Digital Government Regulatory Authority, it offers comprehensive services for all family life stages. This includes marriage to child education support through the "My Family platform."
A key service launched by EHS is "Premarital Genetic Tests," which examines 570 genes to identify potential hereditary diseases. This initiative educates couples about reproductive options to promote healthy families for future generations.
EHS is also presenting its groundbreaking research project "In-Utero Gene Editing" in collaboration with the Children’s Hospital of Philadelphia. This project aims to correct genetic mutations at the DNA level in the liver during pregnancy or shortly after birth using lipid nanoparticles.
AI-Powered Breast Cancer Detection
This gene editing approach targets serious genetic disorders like "Phenylketonuria (PKU)" and "Sickle Cell Anemia," aiming to improve patients' quality of life significantly by reducing future suffering.
For the first time, EHS introduces an innovative early detection programme for breast cancer using artificial intelligence. Developed with the Ministry of Education and Ministry of Health and Prevention, this programme screens teachers using the advanced "Bexa" device known for its precision in detecting tumors.
The Bexa device complements traditional mammography methods by enhancing early detection rates significantly. This improvement in early detection can lead to better survival outcomes for those affected by breast cancer.
With inputs from WAM